Framework for evaluating disease severity measures in older adults with comorbidity

被引:56
作者
Boyd, Cynthia M.
Weiss, Carlos O.
Halter, Jeff
Han, K. Carol
Ershler, William B.
Fried, Linda P.
机构
[1] Johns Hopkins Univ, Sch Med, Ctr Aging & Hlth, Div Geriatr Med & Gerontol, Baltimore, MD 21224 USA
[2] Johns Hopkins Med Inst, Ctr Aging & Hlth, Baltimore, MD 21205 USA
[3] Univ Michigan, Div Geriatr Med, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA
[5] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[6] Inst Adv Studies Aging, Washington, DC USA
来源
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES | 2007年 / 62卷 / 03期
关键词
D O I
10.1093/gerona/62.3.286
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background. Accounting for the influence of concurrent conditions on health and functional status for both research and clinical decision-making purposes is especially important in older adults. Although approaches to classifying severity of individual diseases and conditions have been developed, the utility of these classification systems has not been evaluated in the presence of multiple conditions. Methods. We present a framework for evaluating severity classification systems for common chronic diseases. The framework evaluates the: (a) goal or purpose of the classification system; (b) physiological and/or functional criteria for severity graduation; and (c) potential reliability and validity of the system balanced against burden and costs associated with classification. Results. Approaches to severity classification of individual diseases were not originally conceived for the study of comorbidity. Therefore, they vary greatly in terms of objectives, physiological systems covered, level of severity characterization, reliability and validity, and costs and burdens. Using different severity classification systems to account for differing levels of disease severity in a patient with multiple diseases, or, assessing global disease burden may be challenging. Conclusions. Most approaches to severity classification are not adequate to address comorbidity. Nevertheless, thoughtful use of some existing approaches and refinement of others may advance the study of comorbidity and diagnostic and therapeutic approaches to patients with multimorbidity.
引用
收藏
页码:286 / 295
页数:10
相关论文
共 92 条
  • [1] Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation
    Aaronson, KD
    Schwartz, JS
    Chen, TM
    Wong, KL
    Goin, JE
    Mancini, DM
    [J]. CIRCULATION, 1997, 95 (12) : 2660 - 2667
  • [2] 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension
    Afridi, I
    Canny, J
    Yao, CH
    Christensen, B
    Cooper, RS
    Kadiri, S
    Hill, S
    Kaplan, N
    Kuschnir, E
    Lexchin, J
    Mendis, S
    Poulter, N
    Psaty, BM
    Rahn, KH
    Sheps, SG
    Whitworth, J
    Yach, D
    Bengoa, R
    Ramsay, L
    Kaplan, N
    Mendis, S
    Poulter, N
    Whitworth, J
    [J]. JOURNAL OF HYPERTENSION, 2003, 21 (11) : 1983 - 1992
  • [3] Ahlback S., 1968, Acta Radiol Diagn (Stockh), V277, P7
  • [4] Recommendations for clinical trial evaluation of acute stroke therapies - Stroke Therapy Academic Industry Roundtable II (STAIR-II)
    Albers, GW
    Bogousslavsky, J
    Bozik, MA
    Brass, LM
    Broderick, JP
    Fisher, M
    Goldstein, LB
    Salazar-Grueso, E
    Akitsuki, S
    Aranko, K
    Ashwood, T
    Atkinson, RP
    Bell, RD
    Brott, TG
    Cady, WJ
    Caplan, LR
    Coggins, S
    Cramer, S
    Cyrus, P
    Dayno, J
    Easton, JD
    Elliott, PJ
    Finklestein, SP
    Furlan, AJ
    Gamzu, E
    Glasky, MS
    Gordon, K
    Gorelick, PB
    Greenwood, DT
    Grotta, JC
    Gunn, K
    Hachinski, V
    Hacke, W
    Hall, ED
    Hsu, CY
    Humphreys, DM
    Ishikawa, H
    Jacobs, AJ
    Kaste, M
    Koroshetz, WJ
    Krams, M
    Lauritano, AA
    Leclerc, J
    Lees, KR
    Lesko, L
    Levine, SR
    Levy, DE
    Li, FH
    Lyden, PD
    Masayasu, H
    [J]. STROKE, 2001, 32 (07) : 1598 - 1606
  • [5] Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
  • [6] 2-S
  • [7] Anderson G, 2002, CHRONIC CONDITIONS M
  • [8] [Anonymous], 1999, INT CONSENSUS DIABET
  • [9] BELLAMY N, 1988, J RHEUMATOL, V15, P1833
  • [10] Questionnaires, spirometry and PEF monitoring in epidemiological studies on elderly respiratory patients
    Bellia, V
    Pistelli, F
    Giannini, D
    Scichilone, N
    Catalano, F
    Spatafora, M
    Hopps, R
    Carrozzi, L
    Baldacci, S
    Di Pede, F
    Paggiaro, P
    Viegi, G
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2003, 21 : 21S - 27S